TLP

Tri Locum Partners Portfolio holdings

AUM $330M
1-Year Est. Return 35.44%
This Quarter Est. Return
1 Year Est. Return
+35.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$195M
AUM Growth
-$288M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$18.1M
2
+$16.8M
3
+$10.9M
4
GILD icon
Gilead Sciences
GILD
+$10M
5
ILMN icon
Illumina
ILMN
+$9.58M

Top Sells

1
+$39M
2
+$32.1M
3
+$23.9M
4
VRNA
Verona Pharma
VRNA
+$21.1M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
1
Cigna
CI
$77.7B
$24.3M 12.48%
73,905
+33,095
MCK icon
2
McKesson
MCK
$96.5B
$18.1M 9.3%
+26,944
SLNO icon
3
Soleno Therapeutics
SLNO
$3.61B
$16.8M 8.61%
+234,920
TEVA icon
4
Teva Pharmaceuticals
TEVA
$22.5B
$16.3M 8.37%
1,061,008
-1,362,108
INSP icon
5
Inspire Medical Systems
INSP
$2.29B
$12.6M 6.44%
78,812
-71,976
MDGL icon
6
Madrigal Pharmaceuticals
MDGL
$9.85B
$12.5M 6.44%
37,869
-9,603
AXSM icon
7
Axsome Therapeutics
AXSM
$6.24B
$11.8M 6.06%
101,240
-148,529
ARGX icon
8
argenx
ARGX
$51.6B
$10.6M 5.42%
17,844
-40,414
GILD icon
9
Gilead Sciences
GILD
$146B
$10M 5.14%
+89,453
ILMN icon
10
Illumina
ILMN
$14.7B
$9.58M 4.91%
+120,729
INSM icon
11
Insmed
INSM
$34.5B
$7.77M 3.99%
+101,859
NUVL icon
12
Nuvalent
NUVL
$6.52B
$6.8M 3.49%
+95,825
MRUS icon
13
Merus
MRUS
$7.19B
$6.6M 3.39%
156,915
-190,388
WGS icon
14
GeneDx Holdings
WGS
$3.4B
$5.15M 2.64%
58,145
-69,422
ASND icon
15
Ascendis Pharma
ASND
$12.5B
$5.04M 2.59%
+32,325
BPMC
16
DELISTED
Blueprint Medicines
BPMC
$4.43M 2.27%
+50,000
EOLS icon
17
Evolus
EOLS
$408M
$3.87M 1.99%
321,802
-420,772
VERA icon
18
Vera Therapeutics
VERA
$1.95B
$3.61M 1.85%
+150,207
STVN icon
19
Stevanato
STVN
$6.58B
$3.59M 1.84%
175,681
-946,123
PRAX icon
20
Praxis Precision Medicines
PRAX
$3.42B
$3.17M 1.63%
83,659
+46,390
KRRO icon
21
Korro Bio
KRRO
$456M
$2.24M 1.15%
128,381
-15,835
FEMY icon
22
Femasys
FEMY
$32.1M
$38.3K 0.02%
30,606
AVDL
23
Avadel Pharmaceuticals
AVDL
$1.46B
– –
-1,937,984
BHVN icon
24
Biohaven
BHVN
$1.74B
– –
-140,220
BMY icon
25
Bristol-Myers Squibb
BMY
$88.3B
– –
-355,366
1
2